News and Community

Aln-htt02, Alnylam Alny Stock, Alnylam Pharmaceuticals, Alnylam Rnai Roundtable, Brezosiran, Huntingtin, Huntingtin Lowering, Huntington's Disease, Huntington's Disease Clinical Trial, Huntington's Disease Treatment, Intrathecal Rnai Therapy, Mutant Huntingtin (mhtt), Phase 1b Clinical Trial Results, Rnai Therapeutics

October 23, 2026

Alnylam Reports Positive Phase 1b Brezosiran (ALN-HTT02) Data, Showing Deep and Durable Huntingtin Lowering in Huntington’s Disease

Abuse Potential Assessment, Abuse-deterrent Formulations (adfs), Behavioral Economics, Charles River, Cns-active Compounds, Controlled Substances Act (csa), Drug Development Safety, Drug Scheduling, Fda, Fda Research Collaboration, Healthcare Technology, Labcorp, Preclinical Abuse Potential Studies, Preclinical Models, Public Health Safety, Regulatory Science, Self-administration Studies

October 23, 2026

Charles River, Labcorp, and FDA Team Up to Validate New Preclinical Methods for Abuse Potential Assessment

Advancell Advc001, Advc001 Phase 1, Esmo Congress 2026, Healthcare Technology, Mapmr Prostate Cancer (mcrpc), Metastatic Prostate Cancer Treatment, Psa50 Response Rate, Psma-targeted Therapy, Radioligand Therapy, Radiopharmaceutical Cancer Treatment, Targeted Alpha Therapy, Therapb Clinical Trial

October 23, 2026

AdvanCell Shares Updated ADVC001 Phase 1 Results at ESMO 2026 With Encouraging Long-Term Data

Cells For Life, Coopersurgical, Cord Blood, Cord Blood Banking, Cord Blood Donation, Cord Blood Stem Cells, Dr. Ian Rogers, Healthcare Innovation, Public Cord Blood Bank, Regenerative Medicine, Stem Cell Therapy, University Of Toronto Research, Victoria Angel Registry Of Hope

October 22, 2026

CooperSurgical Donates Over 300 Cord Blood Samples and Additional Funding to Advance Stem Cell Research at the University of Toronto

Disease, Eu Clinical Trial Authorization, Ferrer And Prilenia Therapeutics, Hd Research, Healthcare Technology, Huntington's Disease News, Huntington's Disease Treatment, Neurodegenerative Disease Research, Phase 3 Clinical Trial, Precise-hd Study, Pridopidine

October 22, 2026

Ferrer and Prilenia Receive EU Authorization to Launch Confirmatory PRECISE-HD Study of Pridopidine for Huntington’s Disease

Ai Healthcare Solutions, Ai Voice Agents, Electronic Health Records, Healthcare Ai, Healthcare Appointment Scheduling, Healthcare Digital Transformation, Healthcare Lead Conversion, Healthcare Marketing Automation, Healthcare Revenue Growth, Healthcare Technology, Hipaa-compliant Ai, Invoca Healthcare Ai Solution, Patient Access Management, Patient Acquisition, Patient Appointment Booking, Patient Engagement

October 21, 2026

Invoca Launches Data + AI Healthcare Solution to Boost Patient Appointment Bookings

Automated Molecular Testing, Clinical Laboratory Automation, Diagnostic Laboratory Technology, Flexlab X, Healthcare Technology, High-throughput Testing, Hologic And Inpeco, Hologic Panther System, Laboratory Automation Systems, Laboratory Workflow Automation, Molecular Diagnostics, Molecular Laboratory Automation, Sample Traceability

October 21, 2026

Hologic and Inpeco Partner to Advance Molecular Laboratory Automation

Calcified Coronary Lesions, Calcium Modification, Cardiac Catheterization, Cardiovascular Technology, Coronary Artery Disease, Coronary Artery Treatment, Coronary Intervention, Coronary Ivl Catheter, Healthcare Technology, Heart Disease Treatment, Intravascular Lithotripsy, Ischemic Time, Johnson & Johnson Medtech, Johnson & Johnson Shockwave C2 Aero Fly, Medtech Innovation, Shockwave Ivl

October 21, 2026

Johnson & Johnson Launches Next-Generation Shockwave™ C2 Aero Fly Coronary IVL Catheter to Halve Treatment Time